People taking a widely used medication to strengthen fragile, aging bones may also be protecting their joints, according to a recent study led by Johns Hopkins// rheumatologist Clifton Bingham, M.D.
Researchers began to wonder if risedronate might be used to treat osteoarthritis after noticing that the drug, and other compounds in the same class of drugs, not only slowed joint damage in animals, but also reduced cartilage-irritating bone lesions in humans.
For two years, an international team of investigators studied 2,483 arthritic men and women, from both the United States and Europe. All of those enrolled in the study had a loss in the cartilage that cushions the knee joint, a hallmark symptom of osteoarthritis.
Reporting in the most recent issue of the medical journal Arthritis & Rheumatism, Bingham and his team said study participants were given either a placebo or risedronate at a range of doses, including the standard doses normally prescribed to treat bone loss. The amount of cartilage detected in their knees was measured by X-ray analysis at the one- and two-year marks. Blood tests were also used to check for a marker of cartilage breakdown known as CTX-II.
CTX-II is released in the bloodstreams of people with osteoarthritis when cartilage begins to fray. How fast and to what degree cartilage breaks down can be approximated by levels of CTX-II.
“The blood tests revealed not only that risedronate stabilized bone loss, but also that it was most likely slowing the breakdown of cartilage, too” says Bingham.
Bingham emphasizes that X-rays failed to show any dramatic visible changes in the structure of the joints with risedronate compared to a placebo: however, the numbers of patients exhibiting significant progression of the disease were few in all treatment groups. A great challenge now is identifying the risk factors for joint deterioration in osteoarthritis, adds Bingham.
T
'"/>Page: 1 2 Related medicine news :1.
Drug May Make Breathing Easier for Millions
2.
Proper Validation of Generic Drugs Could Save Millions of AIDS Patients3.
Decoding the Fungi Genome Will Save Millions of Lives.4.
Millions Of Diabetic And Glaucoma Patients Risk Blindness5.
Early Detection Of Primary Liver Cancer Would Save Millions Of Lives6.
WHO Attributes Death of Millions in Africa to Treatable diseases7.
Toll of a Potential Flu Pandemic Runs into Millions8.
NHS Could Save Millions Through Generic Drugs9.
Glaucoma: Silently Stealing Sight from Millions10.
Easy Money-NHS Trusts Make Millions from Parking Fees11.
Ladakh was a Coastal Region Millions of Years Ago